Last reviewed · How we verify
NCT05600790
Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress
NA trial testing Mindfulness Intervention for Emotional Distress in Emotional Distress in 300 participants. Status unknown.
28 February 2023
Quick facts
| Lead sponsor | Peking University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 29 October 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Mindfulness Intervention for Emotional Distress
Conditions studied
- Emotional Distress — all drugs for Emotional Distress →
Sponsor
Peking University
Who can join
Adults 18 to 65, any sex, with Emotional Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study hopes to: 1. explore whether, at the individual level, the improvement of mindfulness ability can promote peace of mind, reduce the frequency of mental wandering, weaken or cut off the cycle between negative mood and mind wandering, and improve the individual's attention monitoring ability and ability to engage in the present. 2. explore the impact of mindfulness intervention on intimate relationships in the eastern culture under the intimate relationship interaction model. 3. explore and propose the level of personality functioning could be a moderator of outcomes of MIED.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05600790
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Intervention for Emotional Distress
Trials testing the same drug.
- NCT05981248 — Experiential Avoidance as the Mechanism of Mindfulness Intervention in Reducing Emotional Distress: Daily Dairy Research · NA · unknown
- NCT05763095 — Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress: Daily Dairy Research · NA · unknown
- NCT05789160 — Experiential Avoidance as Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress · NA · completed
Other recruiting trials for Emotional Distress
Currently open trials in the same condition.
- NCT07436845 — Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arte · recruiting
- NCT06713460 — Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM) · NA · recruiting
- NCT05712057 — Neurostimulation Versus Therapy for Problems With Emotions · NA · recruiting
- NCT05639465 — Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children · NA · recruiting
Other Peking University trials
Trials by the same sponsor.
- NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
- NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
- NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
- NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
- NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05600790 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University
- Last refreshed: 10 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05600790.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing